Advertisement
Screener

MiMedx Group, Inc. (MDXG) Stock Issued During Period, Value, Employee Stock Purchase Plan

MiMedx Group, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • MiMedx Group, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $0.00.
  • MiMedx Group, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $835.00K, a 1.53% decline year-over-year.
  • MiMedx Group, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was -$1.00K.
  • MiMedx Group, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $737.00K, a 6.11% decline year-over-year.
  • MiMedx Group, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $1.58M, a 0.19% increase from fiscal 2024.
  • MiMedx Group, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $1.58M, a 15.73% increase from fiscal 2023.
  • MiMedx Group, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.37M.
  • MiMedx Group, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $0.00.
Period endStock Issued During Period, Value, Employee Stock Purchase Plan 3 monthStock Issued During Period, Value, Employee Stock Purchase Plan 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$1.57M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$835.00K
10-Q · filed 2026-04-29
$1.57M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$1.58M
10-K · filed 2026-02-25
2025-09-30$737.00K
10-Q · filed 2025-10-29
$1.58M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$1.63M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$848.00K
10-Q · filed 2026-04-29
$1.63M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$1.58M
10-K · filed 2026-02-25
2024-09-30$785.00K
10-Q · filed 2025-10-29
$1.58M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30
$1.48M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$797.00K
10-Q · filed 2025-04-30
$1.48M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$1.37M
10-K · filed 2026-02-25
2023-09-30$688.00K
10-Q · filed 2024-10-30
$1.37M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
$680.00K
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$680.00K
10-Q · filed 2024-04-30
$680.00K
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$0.00
10-K · filed 2025-02-26
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
2022-03-31$0.00
10-Q · filed 2023-05-02
2021-12-31$0.00
10-K · filed 2024-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
SpyGlass Pharma, Inc. (SGP)United States$0.925B